Public Health Agency of Canada / Agence de sant‚ publique du Canada
Skip all navigation -accesskey z Skip to sidemenu -accesskey x Skip to main menu -accesskey m Skip all navigation -accesskey z
Français Contact Us Help Search Canada Site
PHAC Home Centres Publications Guidelines A-Z Index
Child Health Adult Health Seniors Health Surveillance Health Canada
    Public Health Agency of Canada (PHAC)
Canada Communicable Disease Report

[Table of Contents]

 

 

Volume: 23S1 - January 1997

Canadian Contingency Plan for Viral Hemorrhagic Fevers and Other Related Diseases

REFERENCES

  1. LCDC. Human plague in India, August-October, 1994. CCDR 1994;20:181-83.

  2. Fritz CL. Surveillance for pneumonic plague. Emerg Infect Dis 1996;2(1):30-6.

  3. Helmick CG, Webb PA, Scribner CL et al. No evidence for increased risk of Lassa fever infection in hospital staff. Lancet 1986;2(8517):1202-05.

  4. Holmes GP, McCormick JB, Trock SC et al. Lassa fever in the United States. N Engl J Med 1990;323:1120-25.

  5. McCormick JB, King IJ, Webb PA et al. Lassa fever, effective therapy with ribavirin. N Engl J Med 1986;314:20-6.

  6. Clayton AJ. Lassa fever, Marburg and Ebola virus diseases and other exotic diseases, is there a risk to Canada? Can Med Assoc J 1979;120:146-55.

  7. CDC. Update: management of patients with suspected viral hemorrhagic fever - United States. MMWR 1995;44:475-79.

  8. McCormick JB, Johnson KM. Lassa fever, historical review and contemporary investigation. In: Pattyn SR, ed. Ebola virus haemorrhagic fever. North Holland: Elsevier, 1978;279-83.

  9. Vainrub B, Salus R. Latin American hemorrhagic fever. Infect Dis Clin North Am 1994;8(1):47-94.

  10. CDC. Management of patients with suspected viral hemorrhagic fever. MMWR 1988;37(S-3):1-15.

  11. Fontenille D, Traore-Lamizana M, Zeller H et al. Rift valley fever in western Africa, isolation from aedes mosquitos during an interepizootic period. Am J Trop Med Hyg 1995;52(5):403-04.

  12. Simpson DIH. Marburg and Ebola virus infections: a guide for their diagnosis, management, and control. Geneva: WHO Offset Publications, No. 36, 1977.

  13. Jahrling RB, Geisbert TW, Dalfard DQW et al. Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet 1990;335:502-05.

  14. Geisbert TW, Jahrling PB, Hanes MA et al. Association of Ebola-related reston virus particles and antigen with issue lesions of monkeys imported to the United States. J Comp Pathol 1992;106:137-52.

  15. Yellow fever in Africa. Lancet 1986; 2(8519):1315-16. Editorial.

  16. Report of a WHO/International Study Team. Ebola haemorrhagic fever in Sudan. 1976. Bull World Health Organ 1978; 56(2):247-70.

  17. Report of an International Commission. Ebola haemorrhagic fever in Zaire. 1976. Bull World Health Organ 1978;56(2):271-93.

  18. Williams EH. 44 contacts of Ebola virus infection, Salisbury. Public Health 1979;96:67-75.

  19. Peters CJ, Jahrling PB, Khan AS. Patients infected with high hazard viruses: scientific basis for infection control. Arch Virol. In press.

  20. Mitchell SW, McCormick JB. Physiochemical inactivation of Lassa, Ebola and Marburg viruses and effect on clinical laboratory analysis. J Clin Microbiol 1984;20(3):486-89.

  21. Elliott LH, McCormick JB, Johnson KM. Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation. J Clin Microbiol 1982;16(4):704-08.

 

[Previous] [Table of Contents]


Last Updated: 2002-11-08 Top
Important Notices